Table 5.
Sensitivity of the chronic liver disease questionnaire: scores (mean ± SD) and effect size
| Scales | Total (n = 460) | CHB (n = 323) | CHB-related cirrhosis (n = 137) | ES |
| AB | 5.48 ± 1.11 | 5.59 ± 1.07 | 5.22 ± 1.16 | 0.331b |
| FA | 4.76 ± 1.11 | 4.82 ± 1.08 | 4.61 ± 1.17 | 0.19 |
| SY | 5.41 ± 0.86 | 5.54 ± 0.82 | 5.09 ± 0.87 | 0.521b |
| AC | 5.45 ± 1.13 | 5.69 ± 1.03 | 4.89 ± 1.15 | 0.711b |
| EM | 4.85 ± 1.10 | 4.87 ± 1.13 | 4.80 ± 1.01 | 0.06 |
| WO | 5.06 ± 1.19 | 5.03 ± 1.23 | 5.11 ± 1.08 | -0.07 |
| Overall | 5.17 ± 0.83 | 5.26 ± 0.83 | 4.95 ± 0.78 | 0.371b |
1
The effect size (ES) ≥ 0.20. Effect size is calculated as the difference between chronic hepatitis B (CHB) and CHB-related cirrhosis groups mean score divided by the overall standard deviation. Significant difference between CHB and CHB-related cirrhosis groups by independent sample t test:
b
P < 0.01. AB: Abdominal symptoms; FA: Fatigue; SY: Systemic symptoms; AC: Activity; EM: Emotional function; WO: Worry.